findmyKOL

Alice Chiu, MD

Basic profile

The University of Texas MD Anderson Cancer Center

ORCIDNone on fileNPI
RegionHouston, TX · South CentralSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Alice Chiu is an Endocrinology/Metabolic physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 6 publications with 927 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
6publications

Distinct works indexed by OpenAlex.

927citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    60.4%
    GLP-1 receptor agonist19.1%
    Ozempic75%Trulicity13%Mounjaro7%Rybelsus4%Victoza 3-Pak1%
    Part D<11 patients
    Insulin Analog14.4%
    Tresiba Flextouch U-10026%Novolog Flexpen21%Tresiba Flextouch U-20014%Humalog Kwikpen U-10010%Lantus Solostar8%Toujeo Solostar5%Novolog4%Levemir Flexpen4%Basaglar Kwikpen U-1003%Lantus2%Fiasp Flextouch2%
    Part D<11 patients

    + 7 more classes in this area

  • Cardiovascular

    27.3%
    Statin14.1%
    Atorvastatin Calcium66%Rosuvastatin Calcium18%Pravastatin Sodium12%Simvastatin4%
    Part D<11 patients
    ACE inhibitor3.6%
    Lisinopril82%Ramipril18%
    Part D<11 patients

    + 9 more classes in this area

  • Hormonal (systemic)

    11.6%
    l-Thyroxine10.8%
    Levothyroxine Sodium83%Synthroid17%
    Part D101 patients
    Thyroid Hormone Synthesis Inhibitor0.8%
    Methimazole100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”